Dr Raymond Chan is Professor of Cancer Nursing, Metro South Health and Queensland University of Technology. Ray’s program of research focuses on optimising the response of health services to the needs of cancer survivors. To date, he has attracted >14 million (AUD) of research project grants as a chief investigator (>$5.4 Million as CIA) to undertake research in supportive cancer care. Prof Chan is a chief investigator for 4 NHMRC project grants, 1 NHMRC Partnership Grant and 1 NHMRC Fellowship, and has published >100 peer-reviewed articles.

Ray is a Past President for the Cancer Nurses Society of Australia, the peak professional body representing over 1,000 cancer nurses across Australia. He currently serves as Chair for the Survivorship Study Group within the Multinational Association for Supportive Care in Cancer and Co-Chair for the Queensland Collaborative for Cancer Survivorship.

Recent funded project highlights include:

• (2020-2024): Implementation of a nurse-enabled, shared-care follow-up model for early Breast cancer survIvorS (The IBIS-Survivorship study). NHMRC (CIA)
• (2020-2023): PROMISE: Patient-Reported Outcome Measures in cancer
  care: a hybrid effectiveness-Implementation trial to
  optimise Symptom control and health service Experience. Cancer Council Queensland (CIB) 
• (2019-2020): ImplEMenting a nurse-coordinated, INtegrated, shared-care model involving specialists and general practitioners in breast cancer post-treatmENT follow-up: a Phase II randomised controlled trial (The EMINENT Trial). Metro South Health (CIA)
• (2017-2018): Financial Toxicity and Symptom Burden in Cancer Survivors. ONS Foundation (CIA)
• (2017-2020): A sequential multiple assignment randomised trial (SMART) of nursing interventions to reduce pain associated with chemotherapy induced peripheral neuropathy. NHMRC (CID)
• (2016-2019): Peripherally InSerted Central catheter Securement: the PISCES Trial. NHMRC (CIC)
• (2014-2017): Development and evaluation of a nurse-led, tailored self-management behavioural intervention for managing distressing symptoms in patients with advanced cancer (The SM2 Study). RBWH Foundation and NHMRC (CIA)
• (2014-2015): Younger women’s wellness after cancer program.  RBWH Foundation (CID)
• (2014): Central venous Access device SeCurement And Dressing Effectiveness in Cancer Care: The CASCADE Trial.  RBWH Foundation (CIA)
• (2013-2016): Improving quality of life in high-risk cancer populations: a randomised trial of a structured intervention for head and neck cancer survivors. NHMRC (CIJ)
• (2012-2013): A double-blind randomised controlled trial of Moogoo Udder Cream® versus aqueous cream for managing radiation-induced skin reactions in patients with cancer.  RBWH Foundation; Office of Health and Medical Research; Cancer Nurses Society of Australia; Moogoo Skincare
• (2011-2014): The RSVP Trial:  Replacement of Intravascular device administration sets after Standard Versus Prolonged use. NHMRC and RBWH Foundation (CIG)
• (2010): Self-management associated with fatigue in patients with advanced cancer. RBWH Foundation, Queensland Nursing Council, Royal College of Nursing Australia (CIA)